Related references
Note: Only part of the references are listed.Bisphosphonate Use and the Risk of Undergoing Total Knee Arthroplasty in Osteoporotic Patients with Osteoarthritis A Nationwide Cohort Study in Taiwan
Shau-Huai Fu et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2017)
Changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A prospective randomized study
Nikolaj Winther et al.
INTERNATIONAL ORTHOPAEDICS (2016)
Local bone quality affects the outcome of prosthetic total knee arthroplasty
Chuan-Ching Huang et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2016)
Periprosthetic tibial bone mineral density changes after total knee arthroplasty A 7-year follow-up of 86 patients
Antti Jaroma et al.
ACTA ORTHOPAEDICA (2016)
Lower Total Knee Arthroplasty Revision Risk Associated With Bisphosphonate Use, Even in Patients With Normal Bone Density
Robert S. Namba et al.
JOURNAL OF ARTHROPLASTY (2016)
Experimental and computational micromechanics at the tibial cement-trabeculae interface
Priyanka Srinivasan et al.
JOURNAL OF BIOMECHANICS (2016)
Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry
Monti Khatod et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2015)
What Host Factors Affect Aseptic Loosening After THA and TKA?
Jeffrey J. Cherian et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2015)
Effect of one-year post-operative alendronate treatment on periprosthetic bone after total knee arthroplasty
A. V. J. Jaroma et al.
BONE & JOINT JOURNAL (2015)
Changes in bone mineral density of the distal femur after total knee arthroplasty: A 7-year DEXA follow-up comparing results between obese and nonobese patients
Jaakko Jarvenpaa et al.
KNEE (2014)
Oral Bisphosphonate Use and Total Knee/Hip Implant Survival Validation of Results in an External Population-Based Cohort
Daniel Prieto-Alhambra et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Quantitative computed tomography assessment of bone mineral density after 2 years' oral bisphosphonate treatment in postmenopausal osteoarthritis patients who underwent total knee arthroplasty
Jin Kyu Lee et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis
J. K. Lee et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Prevention of early bone loss around the prosthesis by administration of anti-osteoporotic agents and influences of collared and non-collared femoral stem prostheses on early periprosthetic bone loss
Wei-Ping Ji et al.
European Journal of Orthopaedic Surgery and Traumatology (2012)
Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials
T. Lin et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Fracture Risk Before and After Total Hip Replacement in Patients With Osteoarthritis Potential Benefits of Bisphosphonate Use
Daniel Prieto-Alhambra et al.
ARTHRITIS AND RHEUMATISM (2011)
The Efficacy of Bisphosphonates in the Prevention of Vertebral, Hip, and Nonvertebral-Nonhip Fractures in Osteoporosis: A Network Meta-Analysis
Jeroen P. Jansen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study
Daniel Prieto-Alhambra et al.
BRITISH MEDICAL JOURNAL (2011)
Loss of Tibial Bone Density in Patients with Rotating- or Fixed-platform TKA
Jacob T. Munro et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2010)
Once-weekly oral medication with alendronate does not prevent migration of knee prostheses
Ulrik Hansson et al.
ACTA ORTHOPAEDICA (2009)
The effect of 6 months oral alendronate treatment on periprosthetic bone loss after total knee arthroplasty
Rashid Barakat Abu-Rajab et al.
EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY (2009)
Aseptic loosening, not only a question of wear - A review of different theories
Mikael Sundfeldt et al.
ACTA ORTHOPAEDICA (2006)
Three-year changes inbone mineral density around the knee after a six-month course of oral alendronate following total knee arthroplasty - A prospective, randomized study
CJ Wang et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2006)
Periprosthetic femoral bone loss after total knee arthroplasty:: 1-year follow-up study of 69 patients
TA Soininvaara et al.
KNEE (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Drugs in development: bisphosphonates and metalloproteinase inhibitors
JB Catterall et al.
ARTHRITIS RESEARCH & THERAPY (2003)
The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty
CJ Wang et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2003)
Effect of alendronate on periprosthetic bone loss after total knee arthroplasty:: A one-year, randomized, controlled trial of 19 patients
TA Soininvaara et al.
CALCIFIED TISSUE INTERNATIONAL (2002)
Meta-analysis of alendronate for the treatment of postmenopausal women
A Cranney et al.
ENDOCRINE REVIEWS (2002)
Distal femoral bone mineral density after total knee arthroplasty: a comparison with general bone mineral density
CJM van Loon et al.
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2001)
Share Paper
